India-based Suven Life Sciences has announced the dosing of the first subjects in its Phase I clinical trial of SUVN-I6107 to ...
Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback